Early Embryo Cleavage And Multiple Pregnancies After ICSI
NCT ID: NCT02265055
Last Updated: 2014-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
193 participants
INTERVENTIONAL
2010-12-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Transfer of Poor-quality Embryos With Good-quality Embryos Improve Pregnancy Outcome in Women Undergoing IVF/ICSI?
NCT03113097
Position Of The Tip Of The Inner Catheter And Air Bubbles As Predictors Of Pregnancy During ICSI Cycles
NCT02942472
Embryoscope and Reproductive Outcome
NCT02764255
Site of Embryo Transfer in Intracytoplasmic Sperm Injection
NCT05004922
Comparative Study to Assess the Ongoing Pregnancy Rate for Poor Responders Women Undergoing Different Embryo Transfer Protocols
NCT05014867
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The controlled ovarian hyperstimulation protocol was performed according to a long GnRH agonist protocol starting in the midluteal phase (day 21) of the preceding cycle. Embryos were assessed at 25 - 27 hr after ICSI for early cleavage. Embryos which reached the two cell stage at this interval were classified as Early Cleavage (EC) embryos, and the remaining as Non Early Cleavage (NEC) embryos. Embryos were assessed again at 64 - 68 hours post-ICSI for day-three embryo morphology. Day 3 embryo transfer was done. The best two or three embryos, according to day 3 embryo morphology were transferred. The patients were subdivided into two subgroups; one will transfer early cleavage embryos (EC) and the other will transfer non early cleavage embryo (NEC).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
transfer early cleavage embryos (EC)
transfer early cleavage embryos
transfer early cleavage embryos
transfer early cleavage embryos
transfer non early cleavage embryo (NEC)
transfer non early cleavage embryos
transfer non early cleavage embryo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transfer early cleavage embryos
transfer early cleavage embryos
transfer non early cleavage embryo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have two ovaries
* Regular cycles
* first ICSI cycle
* Long midluteal GnRH protocol.
Exclusion Criteria
* pelvic masses or diseases (e.g: endometriosis, fibroids, hydrosalpnix, ...)
* history of medical disorders (e.g: hypertension, D.M, thyroid dysfunction, liver diseases, renal diseases,...)
* azoospermia as a cause of male factor infertility
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Edessy Mahmoud
Obstetrics and Gynecology Department, faculty of medicine (Assiut)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
mahmoud edessy, prof
Role: STUDY_DIRECTOR
Al-Azhar University
abd elnasr m ali, prof
Role: PRINCIPAL_INVESTIGATOR
Al-Azhar University
ahmed fata, prof
Role: PRINCIPAL_INVESTIGATOR
Al-Azhar University
wael hamed, dr
Role: STUDY_CHAIR
Al-Azhar University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
u12345
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.